Terms: = Head and neck cancer AND EIF3E, eIF3-p46, 3646, ENSG00000104408, EIF3S6, eIF3e, EIF3-P48, INT6 AND Prognosis
2 results:
1. Effect of previous history of cancer on survival of patients with a second cancer of the head and neck.
Jégu J; Belot A; Borel C; Daubisse-Marliac L; Trétarre B; Ganry O; Guizard AV; Bara S; Troussard X; Bouvier V; Woronoff AS; Colonna M; Velten M
Oral Oncol; 2015 May; 51(5):457-63. PubMed ID: 25687113
[TBL] [Abstract] [Full Text] [Related]
2. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.
Ranieri G; Patruno R; Ruggieri E; Montemurro S; Valerio P; Ribatti D
Curr Med Chem; 2006; 13(16):1845-57. PubMed ID: 16842197
[TBL] [Abstract] [Full Text] [Related]
